Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 3

Research Article

A Platform for Screening Potential Anticholinesterase Fractions and Components Obtained from Anemarrhena asphodeloides Bge for Treating Alzheimer’s Disease

Table 3

The effects of the twenty-five compounds on AChE and BuChE inhibitory activities.

CompoundsAChE inhibition (%)BuChE inhibition (%)

117.9 ± 0.337.6 ± 0.6
215.2 ± 0.228.1 ± 0.4
312.5 ± 0.475.8 ± 0.7
4
514.1 ± 0.335.3 ± 0.5
617.9 ± 0.236.0 ± 0.4
714.2 ± 0.50.6 ± 0.1
8
9
100.9 ± 0.10.1 ± 0.1
117.9 ± 0.34.0 ± 0.2
121.7 ± 0.215.1 ± 0.3
1318.5 ± 0.40.5 ± 0.1
1427.2 ± 0.24.2 ± 0.2
1521.6 ± 0.4
161.1 ± 0.1
1713.2 ± 0.3
1815.9 ± 0.4
1923.5 ± 0.412.3 ± 0.6
2018.4 ± 0.4
2119.2 ± 0.3
2217.3 ± 0.3
2320.3 ± 0.57.3 ± 0.2
2421.1 ± 0.6
2522.4 ± 0.22.8 ± 0.2
Donepezil98.2 ± 0.879.8 ± 0.7